GLP-1 Weight Loss in South Africa: Semaglutide vs Tirzepatide Explained

Weight-loss injections have gone from a niche medical treatment to a global conversation in just a few years — and for good reason: the results in clinical trials are genuinely significant. But if you are considering them in South Africa, the two names you will hear most are semaglutide and tirzepatide, and it is worth understanding how they actually differ. At GenX Clinics in Cape Town, we run doctor-led weight-loss programmes built around these medicines, so here is a clear, honest comparison.

What are GLP-1 medications?

Both semaglutide and tirzepatide belong to a class of medicines that mimic gut hormones your body releases after eating. Semaglutide (the active ingredient in Ozempic and Wegovy) is a GLP-1 receptor agonist. Tirzepatide (Mounjaro) is a dual agonist — it acts on both GLP-1 and a second hormone pathway called GIP. In plain terms, both reduce appetite, slow digestion and improve how your body handles blood sugar, which together support gradual, sustainable weight loss. Tirzepatide simply works on two hormone pathways rather than one.

Semaglutide vs tirzepatide: what the head-to-head trial showed

For a long time these two were compared only indirectly. That changed with SURMOUNT-5, the first direct head-to-head trial, published in the New England Journal of Medicine in 2025. Over 72 weeks, participants on tirzepatide lost on average about 20.2% of their body weight, compared with about 13.7% on semaglutide — roughly 22.8 kg versus 15.0 kg. Around 31.6% of the tirzepatide group lost at least a quarter of their body weight, versus 16.1% on semaglutide. Both improved cardiovascular risk factors such as blood pressure and blood sugar, with tirzepatide showing the larger effect.

So on the numbers, tirzepatide produced greater average weight loss. That does not automatically make it the right choice for everyone — tolerability, cost, availability and your individual health picture all matter, which is exactly what a proper consultation is for.

Which one is right for you?

There is no universal answer. Semaglutide has a longer real-world track record and is widely used; tirzepatide showed greater weight loss in the head-to-head data but may differ in cost and how your body tolerates it. Some people respond better to one than the other, and both are titrated up slowly to manage side effects. The honest answer is that the best choice depends on your goals, medical history, budget and how you respond — which is why these should always be prescribed and monitored by a doctor, not bought off a shelf. We talk this through with every patient and often start with diagnostic testing and an InBody body composition scan so we are tracking fat loss, not just scale weight.

Side effects and safety

The most common side effects of both medicines are gastrointestinal — nausea, changes in digestion, and reduced appetite, especially in the early weeks as the dose increases. These usually settle as your body adjusts, and starting low and going slow helps. They are not suitable for everyone, and they work best as part of a broader programme rather than in isolation.

Why the programme matters more than the molecule

Here is the part that is easy to miss: the medication is a tool, not the whole solution. If lifestyle changes are not adopted alongside treatment, weight tends to return once the medicine stops. That is why our weight-loss programme pairs GLP-1 therapy with proper medical supervision, diagnostics and support for lasting habits — the goal is sustainable results, not a temporary fix. You can see programme details and costs on our pricing page.

The bottom line

Both semaglutide and tirzepatide are genuinely effective, clinically proven weight-loss medicines. Head-to-head, tirzepatide produced greater average weight loss, but the right choice is individual — and either works best inside a supervised programme that builds the habits to keep the weight off. If you are considering weight-loss injections in Cape Town, start with a medical consultation rather than a guess.

Frequently asked questions

Is tirzepatide better than semaglutide?

In the SURMOUNT-5 head-to-head trial, tirzepatide produced greater average weight loss (about 20.2% vs 13.7% over 72 weeks). But better on average does not mean better for everyone — tolerability, cost and your individual response all matter, which is why it is a medical decision.

Can I take these if I am not diabetic?

Yes. Although originally developed for type 2 diabetes, both are used for medically supervised weight management. A consultation determines whether they are appropriate for you.

What are the main side effects?

Most commonly nausea and digestive changes, particularly early on. These usually ease as the dose is increased gradually and your body adjusts.

Will the weight come back if I stop?

It can, if lifestyle changes are not adopted alongside treatment. That is why our programme focuses on sustainable habits, not just the injection.

How much does a weight-loss programme cost at GenX Clinics?

See our pricing page for current programme costs, and we will confirm your specifics at consultation.

This article is for educational purposes only and is not medical advice. GLP-1 medications are prescription treatments that must be prescribed and monitored by a qualified healthcare professional. Always seek medical advice before starting any weight-loss medication, particularly if you are pregnant, breastfeeding, have a medical condition or take regular medication.